LEXICON PHARMACEUTICALS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
LEXICON PHARMACEUTICALS, INC. (LXRX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-05
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-12-31 was $0.00.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2024-09-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-12-31 was $0.00, a 100.00% decline year-over-year.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $0.00.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $0.00.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $307.00K, a 70.19% decline from fiscal 2022.
- LEXICON PHARMACEUTICALS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2022 was $1.03M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 3 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month as first filed | Adjustments to Additional Paid in Capital, Warrant Issued 12 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-05 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 10-K · filed 2026-03-05 | |||||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $0.00 10-Q · filed 2024-11-13 | ||||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-02 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $307.00K derived: sum of 3 quarters · filed 2026-03-05 | $307.00K 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-13 | $307.00K derived: sum of 2 quarters · filed 2024-11-13 | $307.00K 10-Q · filed 2024-11-13 | |||||
| 2023-06-30 | $307.00K 10-Q · filed 2024-11-13 | $307.00K 10-Q · filed 2024-08-02 | ||||||
| 2022-12-31 | $300.00K 10-K · filed 2023-03-03 | $300.00K derived: sum of 2 quarters · filed 2023-11-08 | $300.00K derived: sum of 3 quarters · filed 2023-11-08 | $1.03M 10-K · filed 2025-03-07 | $700.00K 10-K · filed 2023-03-03 | |||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $0.00 derived: sum of 2 quarters · filed 2023-11-08 | $698.00K 10-Q · filed 2023-11-08 | $700.00K 10-Q · filed 2022-11-09 | $698.00K derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $698.00K 10-Q · filed 2023-08-04 | $700.00K 10-Q · filed 2022-08-03 | $698.00K derived: sum of 3 quarters · filed 2024-03-25 | $698.00K derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2022-03-31 | $698.00K 10-Q · filed 2023-11-08 | $700.00K 10-Q · filed 2022-05-05 | $698.00K derived: sum of 2 quarters · filed 2024-03-25 | $698.00K derived: sum of 3 quarters · filed 2024-03-25 | $698.00K derived: sum of 4 quarters · filed 2024-03-25 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 | ||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $0.00 10-Q · filed 2022-08-03 | ||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |